"Maybe they could answer the question, is the 95th biosimilar switching trial likely to show something different to the previous 94?" asks UK oncologist Dr Paul Cornes. …
Latest Video
New Stories
-
New leadership for Bristol-Myers Squibb
October 16, 2018 - - Latest News -
Annual cost of migraine tops $35 billion
October 16, 2018 - - Latest News -
Labor moves to block trade-related PBS changes
October 16, 2018 - - Latest News -
Annual report reveals faster response times
October 16, 2018 - - Latest News -
Lilly's Libby Driscoll: Not 'just another headache'
October 15, 2018 - - Latest News -
The burden of migraine
October 15, 2018 - - Latest News -
Pharmacy backs national consistency on vaccination
October 15, 2018 - - Latest News